Alnylam Pharmaceuticals, Inc. (ALNY)

296.11 -13.38 (-4.32%) USD  |  NASDAQ  |  May 01, 16:00
298.89 +2.78 (+0.94%) After-Hours: 06:29
More

Alnylam Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Glaukos Corp. Upgrade